Sudhir Kumar Singh

Sudhir Kumar Singh

Director Ceo DIN 02607390
DIN 02607390 First appointment Mar 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 4 historical roles
Total affiliations 4 Since Mar 2009
Shareholding value •••• Premium profile

About Sudhir Kumar Singh

Data last updated:

Sudhir Kumar Singh was a Ceo at Cohance Lifesciences Limited (2023–2025), Director at Intox Private Limited (2021–2023) and Whole-Time Director at Jubilant Chemsys Limited (2009–2013), and held 1 more directorship. The companies operate in Pharma.

DIN 02607390
Primary Designation Ceo
Industry Pharma
First Appointment 10 Mar 2009
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cohance Lifesciences Limited L24299MH2018PLC422236
Ceo29 Sep 2023
Intox Private Limited U74999PN2000PTC015116
Director13 Dec 20212000₹45.44 Cr (FY 2025)Active
Jubilant Chemsys Limited U24232UP2004PLC029009
Whole-Time Director10 Mar 20092004₹126 Cr (FY 2019)Amalgamated
Casper Pharma Private Limited U24233MH2016PTC423891
Whole-Time Director01 Dec 20232016₹30.43 Cr (FY 2024)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Casper Pharma Private Limited
Cohance Lifesciences Limited
Intox Private Limited
Jubilant Chemsys Limited
Premium access

Shareholding and investment profile for Sudhir Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Kumar Singh

Sudhir Kumar Singh was first appointed on 10 Mar 2009 as Whole-Time Director at Jubilant Chemsys Limited. The most recent appointment on record is 01 Dec 2023 at Casper Pharma Private Limited.

Sudhir Kumar Singh held 4 earlier board appointments: Cohance Lifesciences Limited (Ceo, 29 Sep 2023 to 31 Jul 2025); Intox Private Limited (Director, 13 Dec 2021 to 18 Apr 2023); Jubilant Chemsys Limited (Whole-Time Director, 10 Mar 2009 to 31 Jan 2013); Casper Pharma Private Limited (Whole-Time Director, from 01 Dec 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available